Given that IDO1 is a well-characterized ISG, known to be stimulated by all three types of IFN signaling41–44, this systemic IDO1 overexpression could be explained by our earlier finding that different immune cell types from people with DS show consistent hyperactivation of the IFN response12. Here, IDO1 is linked to Dravet syndrome.